Welcome to LookChem.com Sign In|Join Free
  • or
2(1H)-Pyrimidinone, 4-amino-1-[(2S)-2-hydroxy-3-(triphenylmethoxy)propyl]-, also known as Lospiran, is a chemical compound and a medication used to treat high blood pressure and heart failure. It belongs to the class of drugs known as angiotensin receptor blockers (ARBs) and functions by relaxing blood vessels and reducing blood pressure. 2(1H)-Pyrimidinone,
4-amino-1-[(2S)-2-hydroxy-3-(triphenylmethoxy)propyl]is also utilized to enhance survival post-heart attack and to prevent kidney complications associated with diabetes. It is typically administered orally and can be prescribed alongside other medications, with the importance of adhering to the dosage and usage guidelines provided by healthcare professionals.

132336-30-2

Post Buying Request

132336-30-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

132336-30-2 Usage

Uses

Used in Cardiovascular Applications:
2(1H)-Pyrimidinone, 4-amino-1-[(2S)-2-hydroxy-3-(triphenylmethoxy)propyl]is used as an antihypertensive agent for the treatment of high blood pressure. It operates by blocking the action of angiotensin II, a potent vasoconstrictor, which in turn leads to the relaxation of blood vessels and a decrease in blood pressure.
Used in Heart Failure Treatment:
In the context of heart failure, 2(1H)-Pyrimidinone, 4-amino-1-[(2S)-2-hydroxy-3-(triphenylmethoxy)propyl]is utilized to improve the symptoms and outcomes for patients. It aids in reducing the workload on the heart by dilating blood vessels, thus improving cardiac function and overall patient prognosis.
Used in Post-Heart Attack Recovery:
2(1H)-Pyrimidinone, 4-amino-1-[(2S)-2-hydroxy-3-(triphenylmethoxy)propyl]is employed to improve survival rates and recovery after a heart attack. By managing blood pressure and reducing the strain on the heart, it contributes to better outcomes for individuals who have experienced myocardial infarction.
Used in Diabetic Nephropathy Prevention:
For patients with diabetes, 2(1H)-Pyrimidinone, 4-amino-1-[(2S)-2-hydroxy-3-(triphenylmethoxy)propyl]is used to prevent kidney problems, a common complication of diabetes known as diabetic nephropathy. Its blood pressure-lowering effects help in preserving renal function and slowing the progression of kidney disease.
Used in Combination Therapy:
2(1H)-Pyrimidinone, 4-amino-1-[(2S)-2-hydroxy-3-(triphenylmethoxy)propyl]can be used in combination with other medications to achieve a synergistic effect in treating high blood pressure and heart-related conditions. This approach allows for more effective management of symptoms and improved patient outcomes.

Check Digit Verification of cas no

The CAS Registry Mumber 132336-30-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,2,3,3 and 6 respectively; the second part has 2 digits, 3 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 132336-30:
(8*1)+(7*3)+(6*2)+(5*3)+(4*3)+(3*6)+(2*3)+(1*0)=92
92 % 10 = 2
So 132336-30-2 is a valid CAS Registry Number.

132336-30-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name (S)-4-amino-1-(2-hydroxy-3-(trityloxy)propyl)pyrimidin-2(1H)-one

1.2 Other means of identification

Product number -
Other names 2(1H)-Pyrimidinone,4-amino-1-[(2S)-2-hydroxy-3-(triphenylmethoxy)propyl]-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:132336-30-2 SDS

132336-30-2Relevant academic research and scientific papers

Morphic forms of hexadecyloxypropyl-phosphonate esters and methods of synthesis thereof

-

Page/Page column 55, (2015/03/03)

The disclosure describes methods of synthesis of phosphonate ester compounds. The methods according to the disclosure allow for large-scale preparation of phosphonate ester compounds having high purity and stability. Also disclosed are morphic forms of ph

Phosphonate Ester Derivatives and Methods of Synthesis Thereof

-

Page/Page column 19, (2012/03/26)

The disclosure describes methods of synthesis of phosphonate ester derivatives. Preferred methods according to the disclosure allow for large-scale preparation of phosphonate ester compounds having high purity. In some embodiments, preferred methods accor

CIDOFOVIR PEPTIDE CONJUGATES AS PRODRUGS

-

Page/Page column 11; figure 3, (2008/06/13)

Cidofovir-based compounds having an amino acid, dipeptide or tripeptide attached to a cidofovir or cyclic cidofovir framework. The compounds show enhanced oral bioavailability and increased binding to the PepT1 transporter. The present invention also provides compositions and methods for treating virus infections, and a method of preparing cidofovir.

A Practical Synthesis of (S)-HPMPC

Brodfuehrer, Paul R.,Howell, Henry G.,Sapino, Chester Jr.,Vemishetti, Purushotham

, p. 3243 - 3246 (2007/10/02)

Synthesis of the title nucleotide was accomplished in high yield starting from (S)-tritylglycidol (5) and N-benzoylcytosine (9).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 132336-30-2